Newsletter Subject

Could this Healthcare Stock really climb 160.22% by 2024?

From

markettickerpress.com

Email Address

editor@markettickerpress.com

Sent On

Wed, Nov 1, 2023 01:17 PM

Email Preheader Text

Earnings Alert. If you cannot see this email properly, please click --------------------------------

Earnings Alert. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- Sponsor Message [Protect Yourself from Biden's Dollar Destruction...]( [I’ve recorded a short 2 minute message that explains everything here. Simply click here now for all of the details.]( --------------------------------------------------------------- November 1, 2023 (Earnings Report) From the desk of the Editor Dear Reader, We just identified several stocks that are expected to release earnings very soon. If you are interested in any of these companies, we encourage you to do your own research and due diligence before pursuing any investments. Keep in mind, the actual earnings date and time may change, so if you’re interested in any of these companies you will need to pay close attention to their announcements. --------------------------------------------------------------- Sponsor Message [[BREAKING] Small Firm Wins $1 Billion Army Contract for Breakthrough "Living Software"]( The Washington Post Reports it's: "A revolution in warfare." The Sunday Times Reports it's: "a revolutionary power." Early investors can reap 5,633% gains as England, Germany, Japan and Australia rush to sign contracts. [Get the name of the stock here ]( --------------------------------------------------------------- [Shopify]( Symbol: [SHOP]( Recent Price: $47.19 Average Analyst Price Target: $65.00 (42.25%) Market Cap: $56.47B Last Year's EPS: $0.01 Consensus EPS Forecast: $0.06 Expected Earnings Date: Nov 02 2023 Recent Analyst Action: Darren Aftahi, analyst at Roth MKM, reiterates coverage on [Shopify (SHOP)]( in the Technology sector with a Buy rating and a price target of $68 (1 day ago). [TipRanks.com]( also reports that [Shopify]( currently has 5 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $65.00 . The target pricing ranges from a high forecast of $75 down to a low forecast of $55. [Shopify (SHOP)](’s last closing price was $47.19 which would put the average price target at 42.25% upside. Here are 3rd party ratings for [SHOP](: - TipRanks.com: Moderate Buy - TradingView.com: Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Top 31% (76 out of 245) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Is This the Computing Giant EV's New Power Plant?]( has a code name within the walls of Apple’s Cupertino headquarters — “Project Titan.” Supposedly one of Steve Jobs’ final projects … a new electric vehicle (EV) that would do for the automotive world what the iPhone did for personal devices. The next generation of EVs, including Project Titan, will get their power from a battery the size of your iPhone. [Click HERE for the full story.]( --------------------------------------------------------------- [Zoetis]( Symbol: [ZTS]( Recent Price: $157 Average Analyst Price Target: $209.60 (40.61%) Market Cap: $72.27B Last Year's EPS: $1.31 Consensus EPS Forecast: $1.32 Expected Earnings Date: Nov 02 2023 Recent Analyst Action: Jonathan Block, analyst at Stifel Nicolaus, reiterates coverage on [Zoetis (ZTS)]( in the Healthcare sector with a Buy rating and a price target of $195 (1 day ago). [TipRanks.com]( also reports that [Zoetis]( currently has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $209.60 . The target pricing ranges from a high forecast of $230 down to a low forecast of $195. [Zoetis (ZTS)](’s last closing price was $157 which would put the average price target at 40.61% upside. Here are 3rd party ratings for [ZTS](: - TipRanks.com: Strong Buy - TradingView.com: Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: sell - Zacks.com: Sell, Top 38% (92 out of 245) [Click for chart >>]( -------------------------------------------------------------------------- [Moderna]( Symbol: [MRNA]( Recent Price: $75.96 Average Analyst Price Target: $129.25 (113.27%) Market Cap: $28.19B Last Year's EPS: $0.19 Consensus EPS Forecast: -$3.84 Expected Earnings Date: Nov 02 2023 Recent Analyst Action: Tyler Van, analyst at TD Cowen, reiterates coverage on [Moderna (MRNA)]( in the Healthcare sector with a Hold rating and a price target of $100 (6 days ago). [TipRanks.com]( also reports that [Moderna]( currently has 4 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $129.25 . The target pricing ranges from a high forecast of $64 down to a low forecast of $100. [Moderna (MRNA)](’s last closing price was $75.96 which would put the average price target at 113.27% upside. Here are 3rd party ratings for [MRNA](: - TipRanks.com: Moderate Buy - TradingView.com: Sell - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Top 27% (66 out of 245) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [My Gift to You]( I have arranged for you to receive [a complimentary 3-month subscription]( to Bernie Schaeffer’s Option Advisor online newsletter. [CLICK HERE]( for 3 Months FREE of Bernie Schaeffer’s Option Advisor ($395 Retail Value - [FREE!]() --------------------------------------------------------------- [Insulet]( Symbol: [PODD]( Recent Price: $132.57 Average Analyst Price Target: $241.75 (86.41%) Market Cap: $9.13B Last Year's EPS: $0.23 Consensus EPS Forecast: $0.26 Expected Earnings Date: Nov 02 2023 Recent Analyst Action: William Plovanic, analyst at Canaccord Genuity, reiterates coverage on [Insulet (PODD)]( in the Healthcare sector with a Buy rating and a price target of $355 (1 week ago). [TipRanks.com]( also reports that [Insulet]( currently has 4 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $241.75 . The target pricing ranges from a high forecast of $355 down to a low forecast of $162. [Insulet (PODD)](’s last closing price was $132.57 which would put the average price target at 86.41% upside. Here are 3rd party ratings for [PODD](: - TipRanks.com: Moderate Buy - TradingView.com: Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Buy, Bottom 41% (145 out of 245) [Click for chart >>]( -------------------------------------------------------------------------- [Lantheus]( Symbol: [LNTH]( Recent Price: $64.60 Average Analyst Price Target: $118.80 (82.40%) Market Cap: $4.21B Last Year's EPS: $1.47 Consensus EPS Forecast: $1.31 Expected Earnings Date: Nov 02 2023 Recent Analyst Action: Roanna Ruiz, analyst at Leerink Partners, reiterates coverage on [Lantheus (LNTH)]( in the Healthcare sector with a Buy rating and a price target of $125 (1 week ago). [TipRanks.com]( also reports that [Lantheus]( currently has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $118.80 . The target pricing ranges from a high forecast of $130 down to a low forecast of $100. [Lantheus (LNTH)](’s last closing price was $64.60 which would put the average price target at 82.40% upside. Here are 3rd party ratings for [LNTH](: - TipRanks.com: Strong Buy - TradingView.com: Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Sell, Bottom 41% (145 out of 245) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Watch SHOCKING Footage of AI Facility with Ties to Elon Musk]( recently traveled more than 3,000 miles and [shot this video outside what could end up being Elon Musk’s biggest secret.]( Most people don’t know about this facility, but it could be the most important AI project in the world. What’s happening inside these walls is so important that our government has declared it a matter of national security. [Click here to see the details because this will definitely impact you and your family.]( --------------------------------------------------------------- [Denali Therapeutics]( Symbol: [DNLI]( Recent Price: $18.83 Average Analyst Price Target: $60.75 (160.22%) Market Cap: $2.53B Last Year's EPS: -$0.8 Consensus EPS Forecast: -$0.68 Expected Earnings Date: Nov 02 2023 Recent Analyst Action: Mayank Mamtani, analyst at B.Riley Financial, reiterates coverage on [Denali Therapeutics (DNLI)]( in the Healthcare sector with a Buy rating and a price target of $37.99 (1 day ago). [TipRanks.com]( also reports that [Denali Therapeutics]( currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $60.75 . The target pricing ranges from a high forecast of $50 down to a low forecast of $105. [Denali Therapeutics (DNLI)](’s last closing price was $18.83 which would put the average price target at 160.22% upside. Here are 3rd party ratings for [DNLI](: - TipRanks.com: Strong Buy - TradingView.com: Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Buy, Top 27% (66 out of 245) [Click for chart >>]( -------------------------------------------------------------------------- [Prothena]( Symbol: [PRTA]( Recent Price: $36.46 Average Analyst Price Target: $76.75 (136.34%) Market Cap: $1.90B Last Year's EPS: -$0.89 Consensus EPS Forecast: -$0.92 Expected Earnings Date: Nov 02 2023 Recent Analyst Action: Tazeen Ahmad, analyst at Bank of America Securities, reiterates coverage on [Prothena (PRTA)]( in the Healthcare sector with a Buy rating and a price target of $70 (5 days ago). [TipRanks.com]( also reports that [Prothena]( currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $76.75 . The target pricing ranges from a high forecast of $94 down to a low forecast of $60. [Prothena (PRTA)](’s last closing price was $36.46 which would put the average price target at 136.34% upside. Here are 3rd party ratings for [PRTA](: - TipRanks.com: Strong Buy - TradingView.com: Sell - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Buy, Top 27% (66 out of 245) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [The #1 Stock Under $5]( Stock-Picking Millionaire Says It’s Not About Diversification! Buy one single $3 stock- that trades under a secret name- and it could help make your retirement. [His instructions are here.]( --------------------------------------------------------------- And there you have it--- Stocks expected to release earnings soon... Sincerely, The Editor, MarketTickerPress.com Market Ticker Press Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. By opening and/or clicking a link containted within this email, you are reconfirming your opt-in status. You can unsubscribe at any time. [If you are not a human, click here.]( MarketTickerPress.com part of Sandpiper Marketing Group | 1519 Mecklenburg Hwy | Unit 4 | Mt. Mourne | North Carolina | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software

Marketing emails from markettickerpress.com

View More
Sent On

04/03/2024

Sent On

03/03/2024

Sent On

03/03/2024

Sent On

03/03/2024

Sent On

02/03/2024

Sent On

02/03/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.